Approvals/TGA/RUBIFEN LA methylphenidate hydrochloride 30 mg modified release capsules blister pack

Approved

STANDARD

RUBIFEN LA methylphenidate hydrochloride 30 mg modified release capsules blister pack

AFT Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 9391dc3be08e4b02
Product Name: RUBIFEN LA methylphenidate hydrochloride 30 mg modified release capsules blister pack
Artg Id: 362232
Artg Name: RUBIFEN LA methylphenidate hydrochloride 30 mg modified release capsules blister pack
Sponsor: AFT Pharmaceuticals Pty Ltd
Company Detail Path: /organization/aft-pharmaceuticals-au-pty-ltd
Artg Date: 2022-05-26
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/ce1ef291f17b6b092893b5782b3230cc.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/a39abb3e934c01bf2e8987cb3be8727b.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

9391dc3be08e4b02

Type

Standard